FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Disopyramide Phosphate (Norpace) Capsules
Status: Currently in Shortage
»Date first posted: 04/18/2014
»Therapeutic Categories: Cardiovascular

Expand all

Pfizer Pharmaceuticals (Reverified 12/06/2018)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Norpace CR 100 mg Capsules; Bottle of 100 (NDC 0025-2732-31) Available

Dear Healthcare Provider Letter - Expiration Date Extension

Other
Norpace CR 100 mg Capsules; Bottle of 500 (NDC 0025-2732-51) Unavailable Shortage per Manufacturer: Presentation Unavailable Other
Norpace CR 150 mg Capsules; Bottle of 100 (NDC 0025-2742-31) Available Other
Norpace CR 150 mg Capsules; Bottle of 500 (NDC 0025-2742-51) Unavailable Shortage per Manufacturer: Presentation Unavailable Other
Norpace 100 mg Capsules; Bottle of 100 (NDC 0025-2752-31) Available Other
Norpace 150 mg Capsules; Bottle of 100 (NDC 0025-2762-31) Available Other

Teva Pharmaceuticals (Reverified 11/30/2018)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Disopyramide phosphate 100 mg capsules, bottle of 100 (NDC 00093-3127-01) Product is currently available.
Disopyramide phosphate 150 mg capsules, bottle of 100 (NDC 00093-3129-01) Product is currently available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English